Literature DB >> 23196787

Incidence and predictive factors for pulmonary metastases after curative resection of colon cancer.

Kazuhiro Watanabe1, Norio Saito, Masanori Sugito, Masaaki Ito, Akihiro Kobayashi, Yusuke Nishizawa.   

Abstract

PURPOSE: To assess the actuarial incidence of pulmonary metastases as the first site of metastasis after R0 resection of colon cancer and to clarify predictive factors for pulmonary metastases as the first site of metastasis.
METHODS: Data for 746 patients who underwent R0 resection for colon cancer from 2000 to 2006 were reviewed. The mean duration of follow-up was 56.9 months.
RESULTS: Pulmonary metastases developed in 35 patients. Mean duration from colon surgery to identification of pulmonary metastases was 20.0 months. The overall occurrence rates of 5-year pulmonary metastasis according to Union for International Cancer Control (UICC) stage were 0.6 % (stage I), 2.2 % (stage II), 9.8 % (stage III), and 24.6 % (stage IV), respectively. Surgery for pulmonary metastases was performed first 18 patients (51.4 %), and 16 (88.9 %) of these 18 patients achieved R0 surgery. Multivariate analysis revealed that presence of regional lymph node involvement and preoperative serum carcinoembryonic antigen level (≥5 ng/ml) were significant independent risk factors for pulmonary metastases. Five-year actuarial incidence of pulmonary metastases increased significantly with increased number of risk factors (0 factors, 2.2 %; 1 factor, 6.6 %; 2 factors, 18.4 %).
CONCLUSIONS: The present study clearly demonstrated predictive factors for pulmonary metastases after R0 resection of colon cancer. Actuarial incidence of pulmonary metastases was significantly related to the number of risk factors present. The data should facilitate the establishment of novel algorithms for predicting pulmonary metastases after resection of colon cancer, which may lead to the appropriate surveillance strategies after colon surgery.

Entities:  

Mesh:

Year:  2012        PMID: 23196787     DOI: 10.1245/s10434-012-2747-y

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN: 1068-9265            Impact factor:   5.344


  15 in total

1.  CT-guided percutaneous radiofrequency ablation for lung metastases from colorectal cancer.

Authors:  Yukiharu Hiyoshi; Yuji Miyamoto; Yuki Kiyozumi; Hiroshi Sawayama; Kojiro Eto; Yohei Nagai; Masaaki Iwatsuki; Shiro Iwagami; Yoshifumi Baba; Naoya Yoshida; Koichi Kawanaka; Yasuyuki Yamashita; Hideo Baba
Journal:  Int J Clin Oncol       Date:  2018-10-17       Impact factor: 3.402

2.  Repeat pulmonary resection for recurrent lung metastases from colorectal cancer: an analysis of prognostic factors.

Authors:  Ayumi Hachimaru; Ryo Maeda; Takashi Suda; Yasushi Takagi
Journal:  Interact Cardiovasc Thorac Surg       Date:  2016-02-25

3.  Does adjuvant chemotherapy improve the prognosis of patients after resection of pulmonary metastasis from colorectal cancer? A systematic review and meta-analysis.

Authors:  Chao Zhang; Yuen Tan; Huimian Xu
Journal:  Int J Colorectal Dis       Date:  2019-08-24       Impact factor: 2.571

Review 4.  Systemic Versus Local Therapies for Colorectal Cancer Pulmonary Metastasis: What to Choose and When?

Authors:  Tony Ibrahim; Lambros Tselikas; Charbel Yazbeck; Joseph Kattan
Journal:  J Gastrointest Cancer       Date:  2016-09

5.  MicroRNA-21 controls hTERT via PTEN in human colorectal cancer cell proliferation.

Authors:  Yang Yang; Jing-Jing Yang; Hui Tao; Wei-Sen Jin
Journal:  J Physiol Biochem       Date:  2015-01-21       Impact factor: 4.158

6.  Role of systemic inflammation scores in pulmonary metastasectomy for colorectal cancer.

Authors:  Tommaso Claudio Mineo; Federico Tacconi
Journal:  Thorac Cancer       Date:  2014-08-25       Impact factor: 3.500

7.  Clinical and Radiological Discrimination of Solitary Pulmonary Lesions in Colorectal Cancer Patients.

Authors:  Yoichi Ohtaki; Kimihiro Shimizu; Toshiteru Nagashima; Seshiru Nakazawa; Kai Obayashi; Yoko Azuma; Misaki Iijima; Takayuki Kosaka; Toshiki Yajima; Hiroomi Ogawa; Soichi Tsutsumi; Motohiro Arai; Akira Mogi; Hiroyuki Kuwano
Journal:  World J Surg       Date:  2018-04       Impact factor: 3.352

8.  Patients with colorectal lung oligometastases (L-OMD) treated by dose adapted SABR at diagnosis of oligometastatic disease have better outcomes than patients previously treated for their metastatic disease.

Authors:  Alina Mihai; Yijia Mu; John Armstrong; Mary Dunne; Sushil Beriwal; Luke Rock; Pierre Thirion; Dwight E Heron; Brian Healy Bird; Jennifer Westrup; Conleth Gerard Murphy; M Saiful Huq; Raymond McDermott
Journal:  J Radiosurg SBRT       Date:  2017

9.  Pulmonary metastasectomy in colorectal cancer: a prospective study of demography and clinical characteristics of 543 patients in the Spanish colorectal metastasectomy registry (GECMP-CCR).

Authors:  R Embún; F Fiorentino; T Treasure; J J Rivas; L Molins
Journal:  BMJ Open       Date:  2013-05-28       Impact factor: 2.692

10.  Association between KRAS mutation and lung metastasis in advanced colorectal cancer.

Authors:  A A L Pereira; J F M Rego; V Morris; M J Overman; C Eng; C R Garrett; A T Boutin; R Ferrarotto; M Lee; Z-Q Jiang; P M Hoff; J-N Vauthey; E Vilar; D Maru; S Kopetz
Journal:  Br J Cancer       Date:  2014-12-23       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.